Thermo Fisher Scientific
TMO
2,375 hedge funds and large institutions have $190B invested in Thermo Fisher Scientific in 2022 Q4 according to their latest regulatory filings, with 236 funds opening new positions, 872 increasing their positions, 926 reducing their positions, and 79 closing their positions.
199% more first-time investments, than exits
New positions opened: 236 | Existing positions closed: 79
17% more call options, than puts
Call options by funds: $1.84B | Put options by funds: $1.58B
8% more capital invested
Capital invested by funds: $176B → $190B (+$13.9B)
5% more funds holding
Funds holding: 2,267 → 2,375 (+108)
0.55% less ownership
Funds ownership: 88.62% → 88.07% (-0.55%)
6% less repeat investments, than reductions
Existing positions increased: 872 | Existing positions reduced: 926
1% less funds holding in top 10
Funds holding in top 10: 238 → 235 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Polen Capital Management
Boca Raton,
Florida
|
+$1.16B |
| 2 |
Morgan Stanley
New York
|
+$935M |
| 3 |
Jennison Associates
New York
|
+$212M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$195M |
| 5 |
Barclays
London,
United Kingdom
|
+$183M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$847M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$822M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$397M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$374M |
| 5 |
ClearBridge Investments
New York
|
-$299M |
TMO Hedge Fund Activity: Q4 2022 in Review
2,375 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2022, worth a combined $190B — up 7.9% from $176B a quarter earlier.
Buyers outnumbered sellers: 236 funds opened new TMO positions and 79 closed out — a net gain of 157 holders — while 872 added to existing stakes and 926 trimmed.
The largest buyer was Polen Capital Management, opening a new position worth an estimated $1.16B. The largest seller was Capital Research Global Investors, cutting an estimated $847M.
- 2,375 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2022, up from 2,267 in Q3 2022.
- Funds reported $190B of Thermo Fisher Scientific stock for Q4 2022, up 7.9% quarter-over-quarter.
- 236 funds opened new Thermo Fisher Scientific positions in Q4 2022 and 79 closed out, a net change of +157 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2022 was Polen Capital Management, an estimated $1.16B added.
- The largest Thermo Fisher Scientific seller in Q4 2022 was Capital Research Global Investors, an estimated $847M sold.
Based on aggregated 13F filings for Q4 2022.